DiGiusto et al. 2010 reports a combinatorial approach that includes Tat/Rev shRNA, Tat activation-response region (TAR) decoy, and CCR5 ribozyme used to genetically modify autologous peripheral blood derived CD34+ HSC from AIDS patients [31]. The gene discussed is TAT; the disease is AIDS.